ArticleBMC research notes2019
Effects of sodium houttuyfonate on transcriptome of Pseudomonas aeruginosa.
Article in BMC research notes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 10 citations in OpenAlex.
- Alkyl ferulic acid esters: Evaluating their structure and antibacterial properties.Frontiers in microbiology · 2023Article
- Sodium New Houttuyfonate InhibitsFrontiers in microbiology · 2020Article
- Effects of sodium houttuyfonate on transcriptome of Pseudomonas aeruginosa.BMC research notes · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
Abstract
objectivesThe purpose of this experiment is to analyze the changes of transcriptome in Pseudomonas aeruginosa under the action of sodium houttuyfonate (SH) to reveal the possible mechanism of SH inhibiting P. aeruginosa. We analyzed these data in order to compare the transcriptomic differences of P. aeruginosa in SH treatment and blank control groups. DATA DESCRIPTION: In this project, RNA-seq of BGISEQ-500 platform was used to sequence the transcriptome of P. aeruginosa, and sequencing data of 8 samples of P. aeruginosa are generated as follows: SH treatment (SH1, SH2, SH3, SH4), negative control (Control 1, Control 2, Control 3, Control 4). Quality control is carried out on raw reads to determine whether the sequencing data is suitable for subsequent analysis. Totally 170.53 MB of transcriptome sequencing data is obtained. Then the filtered clean reads are aligned and compared to the reference genome to proceed second quality control. After completion, 5938 genes are assembled from sequencing data. Further quantitative analysis of genes and screening of differentially expressed genes based on gene expression level reveals that there are 2047 significantly differentially expressed genes under SH treatment, including 368 up-regulated genes and 1679 down-regulated genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.